Abstract
This review presents data on the relationship between inorganic polyphosphate metabolism and carcinogenesis including participation of polyphosphates in the regulation of activity of mTOR and other proteins involved in carcinogenesis, the role of h-prune protein (human polyphosphatase) in cell migration and metastasis formation, the prospects for using polyphosphates and inhibitors of polyphosphate metabolism enzymes as agents for controlling cell proliferation and migration.
Similar content being viewed by others
References
Rao, N. N., Gomez–Garcia, M. R., and Kornberg, A. (2009) Inorganic polyphosphate: essential for growth and survival, Ann. Rev. Biochem., 78, 605–647.
Reusch, R. N. (2012) Physiological importance of poly–(R)–3–hydroxybutyrates, Chem. Biodivers., 9, 2343–2366.
Kuroda, A. (2006) A polyphosphate–Lon protease complex in the adaptation of Escherichia coli to amino acid starvation, Biosci. Biotechnol. Biochem., 70, 325–331.
Azevedo, C., Livermore, T., and Saiardi, A. (2015) Protein polyphosphorylation of lysine residues by inorganic polyphosphate, Mol. Cell, 58, 71–82.
Gray, M. J., Wholey, W. Y., Wagner, N. O., Cremers, C. M., Mueller–Schickert, A., Hock, N. T., Krieger, A. G., Smith, E. M., Bender, R. A., Bardwell, J. C., and Jakob, U. (2014) Polyphosphate is a primordial chaperone, Mol. Cell, 53, 689–699.
Kumble, K. D., and Kornberg, A. (1995) Inorganic polyphosphate in mammalian cells and tissues, J. Biol. Chem., 270, 5818–5822.
Schroder, H. C., Kurz, L., Muller, W. E. G., and Lorenz, B. (2000) Polyphosphate in bone, Biochemistry (Moscow), 65, 296–353.
Muller, F., Mutch, N. J., Schenk, W. A., Smith, S. A., Esterl, L., Spronk, H. M., Schmidbauer, S., Gahl, W. A., Morrissey, J. H., and Renne, T. (2009) Platelet polyphos–phates are proinflammatory and procoagulant mediators in vivo, Cell, 139, 1143–1156.
Docampo, R. (2014) Polyphosphate: a target for thrombosis attenuation, Blood, 124, 3177–3178.
Omelon, S., Georgiou, J., Henneman, Z. J., Wise, L. M., Sukhu, B., Hant, T., Wynnyckyj, S., Holmyard, D., Bielecki, R., and Grynpas, M. D. (2009) Control of vertebrate skeletal mineralization by polyphosphates, PLoS One, 4, e5634.
Mikami, Y., Tsuda, H., Akiyama, Y., Honda, M., Shimizu, N., Suzuki, N., and Komiyama, K. (2016) Alkaline phosphatase determines polyphosphate–induced mineralization in a cell–type independent manner, J. Bone Miner. Metab., 34, 627–637.
Müller, W. E., Wang, X., and Schroder, H. C. (2017) New target sites for treatment of osteoporosis, Prog. Mol. Subcell. Biol., 55, 187–219.
Ruiz, F. A., Lea, C. R., Oldfield, E., and Docampo, R. (2004) Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes, J. Biol. Chem., 279, 44250–44257.
Smith, S. A., and Morrissey, J. H. (2008) Polyphosphate as a general procoagulant agent, J. Thromb. Haemost., 6, 1750–1756.
Muller, F., and Renne, T. (2011) Platelet polyphosphates: the nexus of primary and secondary hemostasis, Scand. J. Clin. Lab. Invest., 71, 82–86.
Hassanian, S. M., Avan, A., and Ardeshirylajimi, A. (2017) Inorganic polyphosphate: a key modulator of inflammation, J. Thromb. Haemost., 15, 213–218.
Zakharian, E., Thyagarajan, B., French, R. J., Pavlov, E., and Rohacs, T. (2009) Inorganic polyphosphate modulates TRPM8 channels, PLoS One, 4, e5404.
Seidlmayer, L. K., Juettner, V. V., Kettlewell, S., Pavlov, E. V., Blatter, L. A., and Dedkova, E. N. (2015) Distinct mPTP activation mechanisms in ischemia–reperfusion: contributions of Ca2+, ROS, pH, and inorganic polyphosphate, Cardiovasc. Res., 106, 237–248.
Baev, A. Y., Negoda, A., and Abramov, A. Y. (2017) Modulation of mitochondrial ion transport by inorganic polyphosphate–essential role in mitochondrial permeability transition pore, J. Bioenerg. Biomembr., 49, 49–55.
Muller, W. E. G., Wang, S., Neufurth, M., Kokkinopoulou, M., Feng, Q., Schroder, H. C., and Wang, X. (2017) Polyphosphate as donor of high–energy phosphate for the synthesis of ADP and ATP, J. Cell Sci., 130, 2747–2756.
Muller, W. E. G., Wang, S., Wiens, M., Neufurth, M., Ackermann, M., Relkovic, D., Kokkinopoulou, M., Feng, Q., Schroder, H. C, and Wang, X. (2017) Uptake of polyphosphate microparticles in vitro (SaOS–2 and HUVEC cells) followed by an increase of the intracellular ATP pool size, PLoS One, 12, e0188977.
Rodic, S., and Vincent, M. D. (2018) Reactive oxygen species (ROS) are a key determinant of cancer’s metabolic phenotype, Int. J. Cancer, 142, 440–448.
Gray, M. J., and Jakob, U. (2015) Oxidative stress protec–tion by polyphosphate–new roles for an old player, Curr. Opin. Microbiol., 24, 1–6.
Wang, L., Fraley, C. D., Faridi, J., Kornberg, A., and Roth, R. A. (2003) Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells, Proc. Natl. Acad. Sci. USA, 100, 11249–1154.
Huang, K., and Fingar, D. C. (2014) Growing knowledge of the mTOR signaling network, Semin. Cell. Dev. Biol., 36, 79–90.
Holroyd, A. K., and Michie, A. M. (2018) The role of mTOR–mediated signaling in the regulation of cellular migration, Immunol. Lett., 196, 74–79.
Laplante, M., and Sabatini, D. M. (2009) mTOR signaling at a glance, J. Cell. Sci., 122, 3589–3594.
Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and age–ing, Nat. Rev. Mol. Cell. Biol., 12, 21–35.
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M. A., Hall, A., and Hall, M. N. (2004) Mammalian TORcomplex 2 controls the actin cytoskeleton and is rapamycin insensitive, Nat. Cell. Biol., 6, 1122–1128.
Hassanian, S. M., Dinarvand, P., Smith, S. A., and Rezaie, A. R. (2015) Inorganic polyphosphate elicits proinflammatory responses through activation of mTOR complexes 1 and 2 in vascular endothelial cells, J. Thromb. Haemost., 13, 860–871.
Hassanian, S. M., Ardeshirylajimi, A., Dinarvand, P., and Rezaie, A. R. (2016) Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/β–catenin signaling in endothelial cells, J. Thromb. Haemost., 14, 2261–2273.
Kornberg, A., Rao, N. N., and Ault–Riche, D. (2009) Inorganic polyphosphate: essential for growth and survival, Annu. Rev. Biochem., 78, 605–647.
Morrissey, J. H., Choi, S. H., and Smith, S. A. (2012) Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation, Blood, 119, 5972–5979.
Jimenez–Nunez, M. D., Moreno–Sanchez, D., Hernandez–Ruiz, L., Benitez–Rondan, A., Ramos–Amaya, A., Rodriguez–Bayona, B., Medina, F., Brieva, J. A., and Ruiz, F. A. (2012) Myeloma cells contain high levels of inorganic polyphosphate which is associated with nucleolar transcription, Haematologica, 97, 1264–1271.
Dedkova, E. N., and Blatter, L. A. (2014) Role of β–hydroxybutyrate, its polymer poly–β–hydroxybutyrate and inorganic polyphosphate in mammalian health and disease, Front. Physiol., 5, 260.
Riehl, A., Nemeth, J., Angel, P., and Hess, J. (2009) The receptor RAGE: bridging inflammation and cancer, Cell. Commun. Signal., 7, 12.
Wan, H. X., Hu, J. H., Xie, R., Yang, S. M., and Dong, H. (2016) Important roles of P2Y receptors in the inflammation and cancer of digestive system, Oncotarget, 7, 28736–28747.
Tammenkoski, M., Koivula, K., Cusanelli, E., Zollo, M., Steegborn, C., Baykov, A. A., and Lahti, R. (2008) Human metastasis regulator protein H–prune is a short–chain exopolyphosphatase, Biochemistry, 47, 9707–9713.
Lonetti, A., Szijgyarto, Z., Bosch, D., Loss, O., Azevedo, C., and Saiardi, A. (2011) Identification of an evolutionarily conserved family of inorganic polyphosphate endopolyphosphatases, J. Biol. Chem., 286, 31966–31974.
Chakraborty, A. (2017) The inositol pyrophosphate pathway in health and diseases, Biol. Rev., 93, 1203–1227.
Grudzien–Nogalska, E., Jiao, X., Song, M. G., Hart, R. P., and Kiledjian, M. (2016) Nudt3 is an mRNA decapping enzyme that modulates cell migration, RNA, 22, 773–781.
D’Angelo, A., Garzia, L., Andre, A., Carotenuto, P., Aglio, V., Guardiola, O., Arrigoni, G., Cossu, A., Palmieri, G., Aravind, L., and Zollo, M. (2004) Prune cAMP phospho–diesterase binds nm23–H1 and promotes cancer metastasis, Cancer Cell, 5, 137–149.
FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest, A. R., Kawaji, H., Rehli, M., Baillie, J. K., de Hoon, M. J., Haberle, V., Lassmann, T., Kulakovskiy, I. V., Lizio, M., Itoh, M., Andersson, R., Mungall, C. J., Meehan, T. F., Schmeier, S., Bertin, N., Jorgensen, M., Dimont, E., Arner, E., Schmidl, C., Schaefer, U., Medvedeva, Y. A., Plessy, C., Vitezic, M., Severin, J., Semple, C., Ishizu, Y., Young, R. S., Francescatto, M., Alam, I., Albanese, D., Altschuler, G. M., Arakawa, T., Archer, J. A., Arner, P., Babina, M., Rennie, S., Balwierz, P. J., Beckhouse, A. G., Pradhan–Bhatt, S., Blake, J. A., Blumenthal, A., Bodega, B., Bonetti, A., Briggs, J., Brombacher, F., Burroughs, A. M., Califano, A., Cannistraci, C. V., Carbajo, D., Chen, Y., Chierici, M., Ciani, Y., Clevers, H. C., Dalla, E., Davis, C. A., Detmar, M., Diehl, A. D., Dohi, T., Drablos, F., Edge, A. S., Edinger, M., Ekwall, K., Endoh, M., Enomoto, H., Fagiolini, M., Fairbairn, L., Fang, H., Farach–Carson, M. C., Faulkner, G. J., Favorov, A. V., Fisher, M. E., Frith, M. C., Fujita, R., Fukuda, S., Furlanello, C., Furino, M., Furusawa, J., Geijtenbeek, T. B., Gibson, A. P., Gingeras, T., Goldowitz, D., Gough, J., Guhl, S., Guler, R., Gustincich, S., Ha, T. J., Hamaguchi, M., Hara, M., Harbers, M., Harshbarger, J., Hasegawa, A., Hasegawa, Y., Hashimoto, T., Herlyn, M., Hitchens, K. J., Ho Sui, S. J., Hofmann, O. M., Hoof, I., Hori, F., Huminiecki, L., Iida, K., Ikawa, T., Jankovic, B. R., Jia, H., Joshi, A., Jurman, G., Kaczkowski, B., Kai, C., Kaida, K., Kaiho, A., Kajiyama, K., Kanamori–Katayama, M., Kasianov, A. S., Kasukawa, T., Katayama, S., Kato, S., Kawaguchi, S., Kawamoto, H., Kawamura, Y. I., Kawashima, T., Kempfle, J. S., Kenna, T. J., Kere, J., Khachigian, L. M., Kitamura, T., Klinken, S. P., Knox, A. J., Kojima, M., Kojima, S., Kondo, N., Koseki, H., Koyasu, S., Krampitz, S., Kubosaki, A., Kwon, A. T., Laros, J. F., Lee, W., Lennartsson, A., Li, K., Lilje, B., Lipovich, L., Mackay–Sim, A., Manabe, R., Mar, J. C., Marchand, B., Mathelier, A., Mejhert, N., Meynert, A., Mizuno, Y., de Lima Morais, D. A., Morikawa, H., Morimoto, M., Moro, K., Motakis, E., Motohashi, H., Mummery, C. L., Murata, M., Nagao–Sato, S., Nakachi, Y., Nakahara, F., Nakamura, T., Nakamura, Y., Nakazato, K., van Nimwegen, E., Ninomiya, N., Nishiyori, H., Noma, S., Noma, S., Noazaki, T., Ogishima, S., Ohkura, N., Ohimiya, H., Ohno, H., Ohshima, M., Okada–Hatakeyama, M., Okazaki, Y., Orlando, V., Ovchinnikov, D. A., Pain, A., Passier, R., Patrikakis, M., Persson, H., Piazza, S., Prendergast, J. G., Rackham, O. J., Ramilowski, J. A., Rashid, M., Ravasi, T., Rizzu, P., Roncador, M., Roy, S., Rye, M. B., Saijyo, E., Sajantila, A., Saka, A., Sakaguchi, S., Sakai, M., Sato, H., Savvi, S., Saxena, A., Schneider, C., Schultes, E. A., Schulze–Tanzil, G. G., Schwegmann, A., Sengstag, T., Sheng, G., Shimoji, H., Shimoni, Y., Shin, J. W., Simon, C., Sugiyama, D., Sugiyama, T., Suzuki, M., Suzuki, N., Swoboda, R. K., ‘t Hoen, P. A., Tagami, M., Takahashi, N., Takai, J., Tanaka, H., Tatsukawa, H., Tatum, Z., Thompson, M., Toyodo, H., Toyoda, T., Valen, E., van de Wetering, M., van den Berg, L. M., Verado, R., Vijayan, D., Vorontsov, I. E., Wasserman, W. W., Watanabe, S., Wells, C. A., Winteringham, L. N., Wolvetang, E., Wood, E. J., Yamaguchi, Y., Yamamoto, M., Yoneda, M., Yonekura, Y., Yoshida, S., Zabierowski, S. E., Zhang, P. G., Zhao, X., Zucchelli, S., Summers, K. M., Suzuki, H., Daub, C. O., Kawai, J., Heutink, P., Hide, W., Freeman, T. C., Lenhard, B., Bajic, V. B., Taylor, M. S., Makeev, V. J., Sandelin, A., Hume, D. A., Carninci, P., and Hayashizaki, Y. (2014) A promoter–level mammalian expression atlas, Nature, 507, 462–470.
Andreeva, N., Lichko, L., Trilisenko, L., Kulakovskiy, I. V., and Kulakovskaya, T. (2016) Yeast polyphosphatases PPX1 and PPN1: properties, functions, and localization, in Inorganic Polyphosphates in Eukaryotic Cells (Kulakovskaya, T., Pavlov, E., and Dedkova, E., eds.), Springer, Cham, pp. 15–33.
Galasso, A., and Zollo, M. (2009) The Nm23–H1–h–prune complex in cellular physiology: a “tip of the iceberg” protein network perspective, Mol. Cell. Biochem., 329, 149–159.
Marino, N., Marshall, J. C., and Steeg, P. S. (2011) Protein–protein interactions: a mechanism regulating the anti–metastatic properties of Nm23–H1, Naunyn Schmiedebergs Arch. Pharmacol., 384, 351–362.
Carotenuto, M., De Antonellis, P., Liguori, L., Benvenuto, G., Magliulo, D., Alonzi, A., Turino, C., Attanasio, C., Damiani, V., Bello, A. M., Vitiello, F., Pasquinelli, R., Terracciano, L., Federico, A., Fusco, A., Freeman, J., Dale, T. C., Decraene, C., Chiappetta, G., Piantedosi, F., Calabrese, C., and Zollo, M. (2014) H–prune through GSK–3β interaction sustains canonical WNT/β–catenin signaling enhancing cancer progression in NSCLC, Oncotarget, 5, 5736–5749.
Hashimoto, M., Kobayashi, T., Tashiro, H., Arihiro, K., Kikuchi, A., and Ohdan, H. (2016) h–prune is associated with poor prognosis and epithelial–mesenchymal transition in patients with colorectal liver metastases, Int. J. Cancer, 139, 812–823.
Oue, N., Yoshida, K., Noguchi, T., Sentani, K., Kikuchi, A., and Yasui, W. (2007) Increased expression of h–prune is associated with tumor progression and poor survival in gastric cancer, Cancer Sci., 98, 1198–1205.
Noguchi, T., Oue, N., Wada, S., Sentani, K., Sakamoto, N., Kikuchi, A., and Yasui, W. (2009) h–prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma, Ann. Surg. Oncol., 16, 1390–1396.
Nambu, J., Kobayashi, T., Hashimoto, M., Tashiro, H., Sugino, K., Shimamoto, F., Kikuchi, A., and Ohdan, H. (2016) h–prune affects anaplastic thyroid cancer invasion and metastasis, Oncol. Rep., 35, 3445–3452.
Han, K. Y., Hong, B. S., Yoon, Y. J., Yoon, C. M., Kim, Y.–K., Kwon, Y.–G., and Gho, Y. S. (2007) Polyphosphate blocks tumor metastasis via anti–angiogenic activity, Biochem. J., 406, 49–55.
Nickel, K. F., Ronquist, G., Langer, F., Labberton, L., Fuchs, T. A., Bokemeyer, C., Sauter, G., Graefen, M., Mackman, N., Stavrou, E. X., Ronquist, G., and Renne, T. (2015) The polyphosphate–factor XII pathway drives coagulation in prostate cancer–associated thrombosis, Blood, 126, 1379–1389.
Sakatani, A., Fujiya, M., Ueno, N., Kashima, S., Sasajima, J., Moriichi, K., Ikuta, K., Tanabe, H., and Kohgo, Y. (2016) Polyphosphate derived from Lactobacillus brevis inhibits colon cancer progression through induction of cell apoptosis, Anticancer Res., 36, 591–598.
Tsutsumi, K., Matsuya, Y., Sugahara, T., Tamura, M., Sawada, S., Fukura, S., Nakano, H., and Date, H. (2017) Inorganic polyphosphate enhances radio–sensitivity in a human non–small cell lung cancer cell line, H1299, Tumor Biol., 39, No. 6; doi: 10.1177/1010428317705033.
Demirkhanyan, L., Elustondo, P., Pavlov, E., and Zakharian, E. (2014) Role of polyphosphate in cancer cell proliferation, Biophys. J., 106, 753a.
Solesio, M. E., and Pavlov, E. V. (2016) Methods of inorganic polyphosphate (PolyP) assay in higher eukaryotic cells, in Inorganic Polyphosphates in Eukaryotic Cells (Kulakovskaya, T., Pavlov, E., and Dedkova, E., eds.), Springer, Cham, pp. 81–89.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E. V. Kulakovskaya, M. Yu. Zemskova, T. V. Kulakovskaya, 2018, published in Biokhimiya, 2018, Vol. 83, No. 8, pp. 1211–1219.
Rights and permissions
About this article
Cite this article
Kulakovskaya, E.V., Zemskova, M.Y. & Kulakovskaya, T.V. Inorganic Polyphosphate and Cancer. Biochemistry Moscow 83, 961–968 (2018). https://doi.org/10.1134/S0006297918080072
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297918080072